Notice of Closed Meeting, 103830 [2024-30238]
Download as PDF
<![CDATA[
103830
Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices
PECOTS (POPULATIONS, EXPOSURES, COMPARATORS, OUTCOMES, TIMING AND SETTING) ELIGIBILITY CRITERIA FOR ALL
KEY QUESTIONS—Continued
Element
Key Question 1
Key Question 2
Key Question 3
Outcomes ..........
HCW burnout, including instruments such as:
• Maslach Burnout Inventory
• Oldenburg Burnout Inventory
• Copenhagen Burnout Inventory
• Two-Item Maslach Burnout Inventory
• Physician Worklife Study Single Item
Question
• Professional Quality of Life (ProQOL)
Burnout scale
• Institute for Professional Worklife Mini Z
Survey
• HCW family outcomes, such as:
Æ Marital/relationship stress measured by
a partner
Æ Divorce/separation rates
• Patient outcomes, such as:
Æ Safety
Æ Satisfaction
Æ Adverse events
Æ Mortality
• Healthcare organization outcomes, such as:
Æ Productivity (including presenteeism,
absenteeism, work-related injuries and
illnesses)
Æ Staff turnover (including due to retirement, leaving the profession, mortality,
or suicide)
• Societal outcomes, such as:
Æ Workforce shortages
HCW burnout, including instruments such as:
• Maslach Burnout Inventory.
• Oldenburg Burnout Inventory.
• Copenhagen Burnout Inventory.
• Two-Item Maslach Burnout Inventory.
• Physician Worklife Study Single Item
Question.
• ProQOL Burnout scale.
• Institute for Professional Worklife Mini Z
Survey.
Mediating Factors.
• Individual factors such as stress, satisfaction, wellbeing, engagement, sleep quality, suicidal ideation, depression, anxiety, meaningful work,
mattering, moral distress or injury, workplace injury or illness.
Modifying Factors.
Æ
Æ
Æ
Æ
Æ
Æ
Æ
Æ
Æ
Study Designs ...
• Cross-sectional studies.
• Cohort studies.
Demographic characteristics: (e.g., age, sex, race, ethnicity).
Occupational title (e.g., physician, nurse, allied health professional, other).
Educational attainment (e.g., high school, some college, college degree, graduate degree).
Experience (e.g., number of years employed).
Income (e.g., household income, socioeconomic status).
Time (e.g., year of outcome ascertainment, or binned by pre-, concurrent and post-pandemic).
Shift characteristics: (e.g., timing, duration, knowledge of shift, mandatory overtime).
Job tasks (e.g., patient-facing vs. non-patient-facing, physical demands as high, moderate, low).
Geographic location (e.g., U.S. census region, urban vs. suburban vs. rural).
• Randomized controlled trials.
• Non-randomized controlled trials.
• Observational cohort studies with a comparison group.
• Pre-post studies (with adjustment for confounders).
Timing ...............
Published since 2014.
Settings .............
All U.S. healthcare delivery settings where HCWs work (e.g., ambulatory, prehospital, emergency, various inpatient services, post-acute or skilled
nursing/long-term care, including medical, surgical, and mental health care settings).
Abbreviations: HCW = healthcare worker; PPE = personal protective equipment, ProQOL = Professional Quality of Life.
Dated: December 12, 2024.
Marquita Cullom,
Associate Director.
[FR Doc. 2024–30259 Filed 12–18–24; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
lotter on DSK11XQN23PROD with NOTICES1
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, pursuant to Public Law 92–
463. The grant applications and the
discussions could disclose confidential
VerDate Sep<11>2014
18:08 Dec 18, 2024
Jkt 265001
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel;
(SEP)—RFA–OH–25–002, Panel A,
Occupational Safety and Health
Education and Research Centers (ERC).
Dates: February 24–25, 2025.
Times: 11:00 a.m.–5:00 p.m., EST.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Dan
Hartley, Ed.D., Scientific Review
Officer, Office of Extramural Programs,
National Institute for Occupational
Safety and Health, Centers for Disease
Control and Prevention, 1095
Willowdale Road, Morgantown, West
Virginia 26505. Telephone: (304) 285–
5812; Email: DHartley@cdc.gov.
PO 00000
Frm 00067
Fmt 4703
Sfmt 9990
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–30238 Filed 12–18–24; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\19DEN1.SGM
19DEN1
]]>Agencies
[Federal Register Volume 89, Number 244 (Thursday, December 19, 2024)]
[Notices]
[Page 103830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30238]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
Centers for Disease Control and Prevention, pursuant to Public Law 92-
463. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel; (SEP)--RFA-OH-25-002, Panel A,
Occupational Safety and Health Education and Research Centers (ERC).
Dates: February 24-25, 2025.
Times: 11:00 a.m.-5:00 p.m., EST.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Dan Hartley, Ed.D., Scientific
Review Officer, Office of Extramural Programs, National Institute for
Occupational Safety and Health, Centers for Disease Control and
Prevention, 1095 Willowdale Road, Morgantown, West Virginia 26505.
Telephone: (304) 285-5812; Email: [email protected].
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-30238 Filed 12-18-24; 8:45 am]
BILLING CODE 4163-18-P
